Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Liabilities and Shareholders Equity (2016 - 2025)

Healthstream (HSTM) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $520.4 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 1.88% to $520.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 0.97% year-over-year, with the annual reading at $520.4 million for FY2025, 1.88% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $520.4 million at Healthstream, up from $499.9 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $524.0 million in Q1 2025, with the low at $477.7 million in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $499.2 million, with a median of $499.7 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity increased 4.19% in 2021, then dropped 3.75% in 2022.
  • Over 5 years, Liabilities and Shareholders Equity stood at $486.8 million in 2021, then increased by 2.26% to $497.7 million in 2022, then grew by 0.44% to $499.9 million in 2023, then increased by 2.17% to $510.8 million in 2024, then rose by 1.88% to $520.4 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $520.4 million, $499.9 million, and $500.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.